| Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors (NCT04990726) | M.D. Anderson Cancer Center | 2019-12-05 |
| Effect of EHealth Coaching Program on Patient Reported Outcomes of Men With Prostate Cancer (NCT04106245) | M.D. Anderson Cancer Center | 2019-12-04 |
| AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT04019288) | M.D. Anderson Cancer Center | 2019-12-03 |
| Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study (NCT04739072) | M.D. Anderson Cancer Center | 2019-11-22 |
| Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer (NCT03830164) | M.D. Anderson Cancer Center | 2019-11-20 |
| Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers (NCT04082572) | M.D. Anderson Cancer Center | 2019-10-31 |
| Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation (NCT03856216) | M.D. Anderson Cancer Center | 2019-10-28 |
| Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT04047641) | M.D. Anderson Cancer Center | 2019-10-22 |
| Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer (NCT04132505) | M.D. Anderson Cancer Center | 2019-10-22 |
| High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors (NCT04151082) | M.D. Anderson Cancer Center | 2019-10-16 |
| Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D) (NCT03896646) | M.D. Anderson Cancer Center | 2019-10-10 |
| Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy (NCT04135326) | M.D. Anderson Cancer Center | 2019-10-10 |
| Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation (NCT03417284) | M.D. Anderson Cancer Center | 2019-10-09 |
| Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African Americans (NCT04236882) | M.D. Anderson Cancer Center | 2019-10-04 |
| Early Metabolic Resuscitation for Septic Shock (NCT03895853) | M.D. Anderson Cancer Center | 2019-10-04 |
| Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures (NCT04171037) | M.D. Anderson Cancer Center | 2019-10-04 |
| CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma (NCT03579927) | M.D. Anderson Cancer Center | 2019-10-03 |
| Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome (NCT04160052) | M.D. Anderson Cancer Center | 2019-10-01 |
| Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers (NCT03968406) | M.D. Anderson Cancer Center | 2019-09-26 |
| Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy (NCT03872388) | M.D. Anderson Cancer Center | 2019-09-23 |
| An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer (NCT04134208) | M.D. Anderson Cancer Center | 2019-09-19 |
| Cordotomy in Reducing Pain in Patients With Advanced Cancer (NCT04119037) | M.D. Anderson Cancer Center | 2019-09-16 |
| Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer (NCT04013542) | M.D. Anderson Cancer Center | 2019-09-13 |
| Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant (NCT03259503) | M.D. Anderson Cancer Center | 2019-09-13 |
| AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission (NCT04062266) | M.D. Anderson Cancer Center | 2019-09-13 |
| Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART) (NCT05084391) | M.D. Anderson Cancer Center | 2019-09-12 |
| HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors (NCT03911388) | M.D. Anderson Cancer Center | 2019-09-12 |
| PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT04022785) | M.D. Anderson Cancer Center | 2019-09-09 |
| nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex (NCT04062305) | M.D. Anderson Cancer Center | 2019-09-09 |
| Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma (NCT04270266) | M.D. Anderson Cancer Center | 2019-09-06 |
| Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT04047797) | M.D. Anderson Cancer Center | 2019-08-28 |
| Project Self in Improving Cervical Cancer Screening Rates in Hispanic and African American Women (NCT04614155) | M.D. Anderson Cancer Center | 2019-08-27 |
| Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans (NCT04215029) | M.D. Anderson Cancer Center | 2019-08-27 |
| Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer (NCT04087057) | M.D. Anderson Cancer Center | 2019-08-23 |
| Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease (NCT04132440) | M.D. Anderson Cancer Center | 2019-08-22 |
| MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation (NCT05087888) | M.D. Anderson Cancer Center | 2019-08-22 |
| Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives (NCT04257045) | M.D. Anderson Cancer Center | 2019-08-21 |
| StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord (NCT03990597) | M.D. Anderson Cancer Center | 2019-08-19 |
| BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers (NCT04021043) | M.D. Anderson Cancer Center | 2019-08-19 |
| Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT03946878) | M.D. Anderson Cancer Center | 2019-08-13 |
| Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma (NCT03531645) | M.D. Anderson Cancer Center | 2019-08-13 |
| CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors (NCT02757391) | M.D. Anderson Cancer Center | 2019-08-09 |
| Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant (NCT03622788) | M.D. Anderson Cancer Center | 2019-08-08 |
| Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study (NCT04430725) | M.D. Anderson Cancer Center | 2019-08-07 |
| Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer (NCT04030455) | M.D. Anderson Cancer Center | 2019-08-07 |
| Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer (NCT04022772) | M.D. Anderson Cancer Center | 2019-07-31 |
| 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer (NCT05130073) | M.D. Anderson Cancer Center | 2019-07-31 |
| Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer (NCT03432676) | M.D. Anderson Cancer Center | 2019-07-31 |
| Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors (NCT03950609) | M.D. Anderson Cancer Center | 2019-07-30 |
| A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors (NCT03784677) | M.D. Anderson Cancer Center | 2019-07-29 |
| Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma (NCT03799445) | M.D. Anderson Cancer Center | 2019-07-25 |
| PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis (NCT04054245) | M.D. Anderson Cancer Center | 2019-07-24 |
| Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma (NCT03990571) | M.D. Anderson Cancer Center | 2019-07-22 |
| Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer (NCT03821792) | M.D. Anderson Cancer Center | 2019-07-22 |
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care (NCT03743649) | M.D. Anderson Cancer Center | 2019-07-17 |
| Parent and Family Obesity Intervention in Reducing Obesity Risk in Racial Ethnic Minority Families (NCT05094466) | M.D. Anderson Cancer Center | 2019-07-16 |
| Financial Distress in Advanced Cancer Patients (NCT04053517) | M.D. Anderson Cancer Center | 2019-07-02 |
| Ibrutinib Plus Rituximab and Lenalidomide in Treating Elderly Participants With Newly Diagnosed Mantle Cell Lymphoma (NCT03232307) | M.D. Anderson Cancer Center | 2019-07-01 |
| Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas (NCT05054335) | M.D. Anderson Cancer Center | 2019-06-20 |
| Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers (NCT05049538) | M.D. Anderson Cancer Center | 2019-06-18 |
| Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor (NCT03884972) | M.D. Anderson Cancer Center | 2019-06-18 |
| Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT04054167) | M.D. Anderson Cancer Center | 2019-06-14 |
| Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer (NCT04017650) | M.D. Anderson Cancer Center | 2019-06-14 |
| Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers (NCT04106843) | M.D. Anderson Cancer Center | 2019-06-13 |
| An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer (NCT04022746) | M.D. Anderson Cancer Center | 2019-06-11 |
| Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer (NCT03207529) | M.D. Anderson Cancer Center | 2019-06-07 |
| Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery (NCT03943173) | M.D. Anderson Cancer Center | 2019-06-07 |
| Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors (NCT04479696) | M.D. Anderson Cancer Center | 2019-06-05 |
| Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study (NCT04256941) | M.D. Anderson Cancer Center | 2019-05-31 |
| Yoga Program for Improving the Quality of Life in Couples Coping With Cancer (NCT04607590) | M.D. Anderson Cancer Center | 2019-05-31 |
| Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer (NCT03987386) | M.D. Anderson Cancer Center | 2019-05-30 |
| An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction (NCT03990610) | M.D. Anderson Cancer Center | 2019-05-24 |
| Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery (NCT04169542) | M.D. Anderson Cancer Center | 2019-05-21 |
| Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors (NCT03830151) | M.D. Anderson Cancer Center | 2019-05-16 |
| Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma (NCT04029038) | M.D. Anderson Cancer Center | 2019-05-15 |
| CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT03896269) | M.D. Anderson Cancer Center | 2019-05-14 |
| Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines (NCT05143619) | M.D. Anderson Cancer Center | 2019-05-10 |
| Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery (NCT04003038) | M.D. Anderson Cancer Center | 2019-05-02 |
| Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT03710772) | M.D. Anderson Cancer Center | 2019-05-01 |
| F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery (NCT03926507) | M.D. Anderson Cancer Center | 2019-04-30 |
| Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03586661) | M.D. Anderson Cancer Center | 2019-04-29 |
| Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease (NCT03868020) | M.D. Anderson Cancer Center | 2019-04-24 |
| Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy (NCT04310826) | M.D. Anderson Cancer Center | 2019-04-23 |
| Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid Prescriptions (NCT03989128) | M.D. Anderson Cancer Center | 2019-04-23 |
| Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine Surgery (NCT04563806) | M.D. Anderson Cancer Center | 2019-04-18 |
| Dietary Intervention in Patients with a History of Melanoma (NCT03950635) | M.D. Anderson Cancer Center | 2019-04-16 |
| Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study (NCT05038852) | M.D. Anderson Cancer Center | 2019-04-12 |
| Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study (NCT04066894) | M.D. Anderson Cancer Center | 2019-04-12 |
| Ultrasound in Evaluating Muscle-Glycogen Content in Cancer Patients (NCT03982082) | M.D. Anderson Cancer Center | 2019-04-12 |
| Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer (NCT03744793) | M.D. Anderson Cancer Center | 2019-04-11 |
| Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant (NCT03622775) | M.D. Anderson Cancer Center | 2019-04-11 |
| Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial Distress (NCT02988271) | M.D. Anderson Cancer Center | 2019-04-11 |
| Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers (NCT03892993) | M.D. Anderson Cancer Center | 2019-04-09 |
| Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies (NCT05108519) | M.D. Anderson Cancer Center | 2019-04-08 |
| Comprehensive Lifestyle Change To Prevent Breast Cancer (NCT03448003) | M.D. Anderson Cancer Center | 2019-04-04 |
| Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain (NCT04239976) | M.D. Anderson Cancer Center | 2019-04-04 |
| Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia (NCT03808610) | M.D. Anderson Cancer Center | 2019-04-03 |
| Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers (NCT04629677) | M.D. Anderson Cancer Center | 2019-04-02 |
| Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer (NCT04678414) | M.D. Anderson Cancer Center | 2019-04-01 |
| Durvalumab, Tremelimumab, and Selumetinib in Treating Participants With Recurrent or Stage IV Non-small Cell Lung Cancer (NCT03581487) | M.D. Anderson Cancer Center | 2019-04-01 |